Global Colorectal Cancer Diagnostics & Therapeutics Market Growth of 1-5% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2015-2020 - Key Vendors: Alere, Fujirebio, Metabiomics - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Colorectal Cancer Diagnostics & Therapeutics Market - Segmented by diagnosis, technology and geography (2015 - 2020)" report to their offering.

The global colorectal cancer diagnostics and therapeutics market is expected to grow at a compound annual growth rate (CAGR) of 1-5% during the forecast period of 2015-2020. The market is valued at USD 14,143 million, as per 2015.

The CRC pipeline is highly robust, with a number of potential drug candidates present across the various phases of clinical development. With nearly 400 active pipeline molecules, the majority of the investigational drug candidates are being evaluated for the treatment of CRC in advanced stages, either as first-line or as second-line therapies.

The current investigational pipeline candidates include new combination therapies and targeted therapies, as well as promising immunotherapies and chemotherapy drug candidates. Along with these active progressing pipeline molecules, the pipeline also includes nearly 180 molecules that are either inactive or discontinued.

The global colorectal cancer diagnostics and therapeutics market is segmented on the basis of:

  • Diagnosis
  • Digital rectal examination
  • Fecal occult blood test
  • Flexible sigmoidoscopy
  • Colonoscopy
  • Others
  • Treatments
  • Surgery and radiation therapy
  • Targeted therapies
  • Others
  • Geography
  • North America
  • Asia-Pacific
  • Europe
  • Rest of the world

Companies Mentioned:

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Clinical Genomics
  • Companion Dx
  • EDP Biotech
  • Epigenomics AG
  • Exact Sciences
  • Fujirebio
  • Genomic Tree
  • Metabiomics
  • Oncocyte (Biotime)
  • Quest Diagnostics
  • Randox Laboratories
  • Siemens Healthcare
  • Volition Rx.

Report Structure:

1. Introduction

2 Executive summary

3. Market overview

4. Portors five force analysis

5. Market segmentation

6.Competitive Landscape

7. Company profiles

8Appendix

For more information visit http://www.researchandmarkets.com/research/lzdj73/global_colorectal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics, Colon Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics, Colon Cancer Drugs